Design of growth factor sequestering biomaterials

被引:81
作者
Belair, David G. [1 ]
Ngoc Nhi Le [2 ]
Murphy, William L. [1 ,2 ]
机构
[1] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA
[2] Univ Wisconsin, Dept Mat Sci, Madison, WI USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
HEPARIN-BINDING PEPTIDES; AMINO-ACID SUBSTITUTION; HUMAN APOLIPOPROTEIN-E; LATENT TGF-BETA; EXTRACELLULAR-MATRIX; FACTOR-RECEPTOR; CONTROLLED-RELEASE; ENDOTHELIAL-CELLS; MIMETIC PEPTIDE; FACTOR VEGF;
D O I
10.1039/c4cc04317k
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Growth factors (GFs) are major regulatory proteins that can govern cell fate, migration, and organization. Numerous aspects of the cell milieu can modulate cell responses to GFs, and GF regulation is often achieved by the native extracellular matrix (ECM). For example, the ECM can sequester GFs and thereby control GF bioavailability. In addition, GFs can exert distinct effects depending on whether they are sequestered in solution, at two-dimensional interfaces, or within three-dimensional matrices. Understanding how the context of GF sequestering impacts cell function in the native ECM can instruct the design of soluble or insoluble GF sequestering moieties, which can then be used in a variety of bioengineering applications. This Feature Article provides an overview of the natural mechanisms of GF sequestering in the cell milieu, and reviews the recent bioengineering approaches that have sequestered GFs to modulate cell function. Results to date demonstrate that the cell response to GF sequestering depends on the affinity of the sequestering interaction, the spatial proximity of sequestering in relation to cells, the source of the GF (supplemented or endogenous), and the phase of the sequestering moiety (soluble or insoluble). We highlight the importance of context for the future design of biomaterials that can leverage endogenous molecules in the cell milieu and mitigate the need for supplemented factors.
引用
收藏
页码:15651 / 15668
页数:18
相关论文
共 213 条
[11]   Specific VEGF sequestering to biomaterials: Influence of serum stability [J].
Belair, David G. ;
Murphy, William L. .
ACTA BIOMATERIALIA, 2013, 9 (11) :8823-8831
[12]   Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model [J].
Bergmann, Astrid ;
Ahmad, Shakil ;
Cudmore, Melissa ;
Gruber, Achim D. ;
Wittschen, Petra ;
Lindenmaier, Werner ;
Christofori, Gerhard ;
Gross, Volkmar ;
da Costa Gonzalves, Andrey Ch ;
Groene, Hermann-Josef ;
Ahmed, Asif ;
Weich, Herbert A. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (6B) :1857-1867
[13]   Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model [J].
Bhattacharjee, Partha S. ;
Neumann, Donna M. ;
Foster, Timothy P. ;
Clement, Christian ;
Singh, Gyanendra ;
Thompson, Hilary W. ;
Kaufman, Herbert E. ;
Hill, James M. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (10) :4263-4268
[14]   A Novel Peptide Derived from Human Apolipoprotein E Is an Inhibitor of Tumor Growth and Ocular Angiogenesis [J].
Bhattacharjee, Partha S. ;
Huq, Tashfin S. ;
Mandal, Tarun K. ;
Graves, Richard A. ;
Muniruzzaman, Syed ;
Clement, Christian ;
McFerrin, Harris E. ;
Hill, James M. .
PLOS ONE, 2011, 6 (01)
[15]   Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis [J].
Binétruy-Tournaire, R ;
Demangel, C ;
Malavaud, B ;
Vassy, R ;
Rouyre, S ;
Kraemer, M ;
Plouët, J ;
Derbin, C ;
Perret, G ;
Mazie, JC .
EMBO JOURNAL, 2000, 19 (07) :1525-1533
[16]   Heparan sulphate proteoglycans fine-tune mammalian physiology [J].
Bishop, Joseph R. ;
Schuksz, Manuela ;
Esko, Jeffrey D. .
NATURE, 2007, 446 (7139) :1030-1037
[17]   Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice [J].
Blaskovich, MA ;
Lin, Q ;
Delarue, FL ;
Sun, J ;
Park, HS ;
Coppola, D ;
Hamilton, AD ;
Sebti, SM .
NATURE BIOTECHNOLOGY, 2000, 18 (10) :1065-1070
[18]   The 1.1 Å crystal structure of human TGF-β type II receptor ligand binding domain [J].
Boesen, CC ;
Radaev, S ;
Motyka, SA ;
Patamawenu, A ;
Sun, PD .
STRUCTURE, 2002, 10 (07) :913-919
[19]   Minimizing a binding domain from protein A [J].
Braisted, AC ;
Wells, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5688-5692
[20]   Identification of a cyclic peptide inhibitor of platelet-derived growth factor-BB receptor-binding and mitogen-induced DNA synthesis in human fibroblasts [J].
Brennand, DM ;
Dennehy, U ;
Ellis, V ;
Scully, MF ;
Tripathi, P ;
Kakkar, VV ;
Patel, G .
FEBS LETTERS, 1997, 413 (01) :70-74